ARTICLE | Clinical News
Cleveland BioLabs preclinical data
July 9, 2012 7:00 AM UTC
In a mouse model of neuroblastoma, both oral and IV CBL0137 plus standard chemotherapy - cyclophosphamide and topotecan - led to complete tumor regression in 100% of mice vs. 0% for CBL0137 alone and ...